Cargando…

Different clinical impact of hyperuricemia according to etiologies of chronic kidney disease: Gonryo Study

BACKGROUND: Hyperuricemia is highly prevalent in chronic kidney disease (CKD) patients, but the evidence for a relationship between uric acid (UA) and clinical outcomes in CKD patients is limited and inconsistent. We hypothesized that UA has a different impact on clinical outcomes according to the u...

Descripción completa

Detalles Bibliográficos
Autores principales:	Watanabe, Kimio, Nakayama, Masaaki, Yamamoto, Tae, Yamada, Gen, Sato, Hiroshi, Miyazaki, Mariko, Ito, Sadayoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993817/ https://www.ncbi.nlm.nih.gov/pubmed/33765101 http://dx.doi.org/10.1371/journal.pone.0249240

Ejemplares similares

Impact of lower body mass index on risk of all-cause mortality and infection-related death in Japanese chronic kidney disease patients
por: Yamamoto, Tae, et al.
Publicado: (2020)

(Pro)renin receptor is involved in mesangial fibrosis and matrix expansion
por: Narumi, Kaori, et al.
Publicado: (2018)

Possible clinical effects of molecular hydrogen (H(2)) delivery during hemodialysis in chronic dialysis patients: Interim analysis in a 12 month observation
por: Nakayama, Masaaki, et al.
Publicado: (2017)

What’s New in the Molecular Mechanisms of Diabetic Kidney Disease: Recent Advances
por: Watanabe, Kimio, et al.
Publicado: (2022)

Dissolved molecular hydrogen (H(2)) in Peritoneal Dialysis (PD) solutions preserves mesothelial cells and peritoneal membrane integrity
por: Nakayama, Masaaki, et al.
Publicado: (2017)

Effect of uremic toxins on hippocampal cell damage: analysis in vitro and in rat model of chronic kidney disease
por: Watanabe, Kimio, et al.
Publicado: (2021)

Febuxostat for Hyperuricemia in Patients with Advanced Chronic Kidney Disease
por: Akimoto, Tetsu, et al.
Publicado: (2014)

Nicotinamide Attenuates the Progression of Renal Failure in a Mouse Model of Adenine-Induced Chronic Kidney Disease
por: Kumakura, Satoshi, et al.
Publicado: (2021)

Skin Autofluorescence Is Associated with the Progression of Chronic Kidney Disease: A Prospective Observational Study
por: Tanaka, Kenichi, et al.
Publicado: (2013)

Novel haemodialysis (HD) treatment employing molecular hydrogen (H(2))-enriched dialysis solution improves prognosis of chronic dialysis patients: A prospective observational study
por: Nakayama, Masaaki, et al.
Publicado: (2018)

SAT-079 Renal Protective Effects Of Topiroxostat And Febuxostat In Hypertensives With Hyperuricemia.
por: Satoh, Fumitoshi, et al.
Publicado: (2019)

The effect of febuxostat to prevent a further reduction in renal function of patients with hyperuricemia who have never had gout and are complicated by chronic kidney disease stage 3: study protocol for a multicenter randomized controlled study
por: Hosoya, Tatsuo, et al.
Publicado: (2014)

A Catastrophic Case of Idiopathic Cholesterol Crystal Embolism with Multiple Lethal Complications: A Labyrinth Underneath the Diagnosis of Skin Ulcers in Chronic Kidney Disease Patients
por: Kumakura, Satoshi, et al.
Publicado: (2019)

Renal interstitial fibroblasts coproduce erythropoietin and renin under anaemic conditions
por: Miyauchi, Kenichiro, et al.
Publicado: (2021)

The grey zone of Hyperuricemia in chronic kidney disease
por: Dousdampanis, Periklis
Publicado: (2017)

Hyperuricemia and chronic kidney disease: to treat or not to treat
por: Piani, Federica, et al.
Publicado: (2021)

Enhanced neutrophil apoptosis accompanying myeloperoxidase release during hemodialysis
por: Fukushi, Taro, et al.
Publicado: (2020)

To treat or not to treat asymptomatic hyperuricemia in chronic kidney disease
por: Shin, Dong Ho
Publicado: (2019)

SAT-058 Histopathological Analysis of Kidneys and Adrenal Glands in the Same Primary Aldosteronism (PA) Patients: Exploring the Mechanisms of Aldosterone Specific Renal Injuries
por: Ogata, Hiroko, et al.
Publicado: (2019)

Hyperuricemia, the heart, and the kidneys – to treat or not to treat?
por: Petreski, Tadej, et al.
Publicado: (2020)

Utility of Serum Albumin for Predicting Incident Metabolic Syndrome According to Hyperuricemia
por: Lee, You-Bin, et al.
Publicado: (2018)

Association between Dietary Fat Intake and Hyperuricemia in Men with Chronic Kidney Disease
por: Oku, Fumika, et al.
Publicado: (2022)

Traditional Chinese Herbal Medicine Plays a Role in the Liver, Kidney, and Intestine to Ameliorate Hyperuricemia according to Experimental Studies
por: Xu, Li, et al.
Publicado: (2021)

Influence of hyperuricemia treatment on postoperative acute kidney injury among hyperuricemia patients: a single-center retrospective database analysis
por: Watanabe, Shinichiro, et al.
Publicado: (2019)

Development of acute kidney injury with massive granular casts and microscopic hematuria in patients with COVID-19: two case presentations with literature review
por: Fujimaru, Takuya, et al.
Publicado: (2020)

Associations Between Hyperuricemia and Chronic Kidney Disease: A Review
por: Prasad Sah, Om Shankar, et al.
Publicado: (2015)

Sex Differences in Time-Series Changes in Pseudo-R(2) Values Regarding Hyperuricemia in Relation to the Kidney Prognosis
por: Kataoka, Hiroshi, et al.
Publicado: (2020)

The Effect of Alcoholic Beverage Type on Hyperuricemia in Japanese Male Office Workers
por: Sugie, Takuya, et al.
Publicado: (2005)

Molecular Biological and Clinical Understanding of the Pathophysiology and Treatments of Hyperuricemia and Its Association with Metabolic Syndrome, Cardiovascular Diseases and Chronic Kidney Disease
por: Yanai, Hidekatsu, et al.
Publicado: (2021)

Allopurinol for prevention of progression of kidney disease with hyperuricemia
por: Pai, B. H. Santhosh, et al.
Publicado: (2013)

Effect of Behavior Modification on Outcome in Early- to Moderate-Stage Chronic Kidney Disease: A Cluster-Randomized Trial
por: Yamagata, Kunihiro, et al.
Publicado: (2016)

Role of asymptomatic hyperuricemia in the progression of chronic kidney disease and cardiovascular disease
por: Waheed, Yousuf, et al.
Publicado: (2021)

Antihypertensive effects and safety of esaxerenone in patients with moderate kidney dysfunction
por: Ito, Sadayoshi, et al.
Publicado: (2020)

Treatment of Refractory Hypertension with Timely Angioplasty in Total Renal Artery Occlusion with Atrophic Kidney
por: Sasaki, Yuri, et al.
Publicado: (2020)

Myeloid cell-derived coagulation tissue factor is associated with renal tubular damage in mice fed an adenine diet
por: Yamakage, Shu, et al.
Publicado: (2021)

Joint association of hyperuricemia and chronic kidney disease with mortality in patients with chronic heart failure
por: Wang, Chi, et al.
Publicado: (2023)

Asymptomatic hyperuricemia and chronic kidney disease: Narrative review of a treatment controversial
por: Eleftheriadis, Theodoros, et al.
Publicado: (2017)

Management of Hyperuricemia in Patients with Chronic Kidney Disease: a Focus on Renal Protection
por: Kielstein, Jan T., et al.
Publicado: (2020)

Traditional Chinese herbs and natural products in hyperuricemia-induced chronic kidney disease
por: Yang, Letian, et al.
Publicado: (2022)

Decreased extra-renal urate excretion is a common cause of hyperuricemia
por: Ichida, Kimiyoshi, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ul5o41jg4llsl7tjhg1968c61d